NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 5.086
EU - Europa 3.382
AS - Asia 1.130
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 10
AF - Africa 7
OC - Oceania 4
Totale 9.633
Nazione #
US - Stati Uniti d'America 5.063
IT - Italia 1.218
GB - Regno Unito 954
SE - Svezia 413
CN - Cina 362
SG - Singapore 325
DE - Germania 225
TR - Turchia 208
HK - Hong Kong 164
UA - Ucraina 163
FI - Finlandia 95
FR - Francia 70
BG - Bulgaria 63
RU - Federazione Russa 63
IN - India 25
IR - Iran 21
NL - Olanda 21
CA - Canada 18
BE - Belgio 16
IE - Irlanda 16
LT - Lituania 14
EU - Europa 12
SI - Slovenia 11
CH - Svizzera 9
ID - Indonesia 8
ES - Italia 6
PL - Polonia 6
BR - Brasile 5
CO - Colombia 4
MY - Malesia 4
AT - Austria 3
AU - Australia 3
RO - Romania 3
RS - Serbia 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
CU - Cuba 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
MG - Madagascar 2
PA - Panama 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EG - Egitto 1
HR - Croazia 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SM - San Marino 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 9.633
Città #
Southend 832
Santa Clara 785
Woodbridge 496
Fairfield 433
Chandler 429
Jacksonville 351
Ashburn 329
Ann Arbor 260
Houston 258
Singapore 254
Nyköping 246
Dearborn 234
Wilmington 195
Seattle 168
Hong Kong 163
Cambridge 150
Beijing 142
Izmir 120
Milan 91
Rome 86
Princeton 70
Sofia 62
Eugene 61
San Diego 61
Modena 51
Naples 42
Des Moines 37
Frankfurt am Main 37
Helsinki 37
New York 33
Shanghai 31
Bologna 24
Florence 23
Moscow 23
London 21
Philadelphia 20
Dublin 16
Palermo 16
Redwood City 16
Turin 16
Bari 15
Brussels 15
San Mateo 15
Brescia 14
Boardman 13
Catania 13
Guangzhou 12
Norwalk 12
Los Angeles 11
Augusta 10
Falls Church 10
Hefei 10
Mashhad 10
Nanjing 10
Ottawa 10
Verona 10
Bremen 9
Grafing 9
Parma 9
Pescara 9
Ardabil 8
Cosenza 8
Jakarta 8
Kunming 8
Munich 8
Treviso 8
Bergamo 7
Padova 7
Perugia 7
Pisa 7
Carpi 6
Ferrara 6
Jinan 6
Piacenza 6
Rio Saliceto 6
Toronto 6
Genoa 5
Indiana 5
Kraków 5
Legnano 5
Monmouth Junction 5
Saint-martin-du-tertre 5
Trieste 5
Angri 4
Auburn Hills 4
Bangalore 4
Cascina 4
Changsha 4
Chiswick 4
Crispano 4
Frascati 4
Fucecchio 4
Grantorto 4
Limbiate 4
Mumbai 4
San Martino Siccomario 4
Torre del Greco 4
Amalfi 3
Belgrade 3
Borås 3
Totale 7.157
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.195
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 224
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 213
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized study. 210
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 194
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 193
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 189
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 187
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 184
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 173
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 168
Detectable HIV viral load is associated with metabolic syndrome. 164
Age-related comorbidities in people living with HIV 161
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 160
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 159
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 155
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 155
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 151
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 148
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 148
Virologic failure and metabolic syndrome in patients with HIV infection 146
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 143
Severity of lipodystrophy is associated with decreased health-related quality of life 143
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 143
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 143
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 141
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 138
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 137
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 137
Virologic failure and metabolic syndrome in patients with HIV infection 137
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 133
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 133
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 132
How do frailty mediate pathway leading to disability 131
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 130
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 127
Relapse of HIV-related buffalo hump after liposuction 127
Does lipodistrophy affect quality of life? 126
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 125
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 124
È possibile un counselling HIV su internet? 122
Validity of body image perception in women with HIV. 121
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 120
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 117
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 117
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 116
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 115
Body Image perception in HIV infected women with body fat redistribution. 114
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 113
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 113
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 109
Lipodystrophy and quality of life: a prospective study 107
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 105
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 104
Prevalence and risk factors of pubic lipomas in HIV-infected patients 103
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 103
Qual è il rapporto tra qualità di vita e lipodistrofia 99
HIV counselling looks for new target and methods web versus face to face counselling 98
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 97
HIV counselling and prevention on the WEB 97
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 94
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 91
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 67
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 51
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 34
Totale 9.754
Categoria #
all - tutte 33.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020818 0 0 0 0 0 0 264 217 114 44 103 76
2020/20211.215 100 43 103 118 182 71 109 131 82 118 95 63
2021/2022987 21 158 63 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20251.633 117 69 73 227 624 427 96 0 0 0 0 0
Totale 9.754